Browse diseases

…s from the Central Finland Biobank who have been diagnosed with type 2 diabetes and have consented to recall will be invited to participate in …

…tes prevention programmes (DPPs) effectively reduce the risk of type 2 diabetes, optimising referral to these programmes is challenging. Our pr…

…yond hunger and is linked to adverse health outcomes, including cardiovascular disease, obesity, type 2 diabetes, hypertension, increased risk of birt…

…sive forms of sucrose intolerance but also to increased risk of irritable bowel syndrome (IBS), its severity and the efficacy of carbohydrate-reducing d…

…LREs (110 (2.5%) with hepatic decompensation and 59 (1.3%) with hepatocellular carcinoma). The two-step approach classified 72.6%, 6.8% and 20.6% of pat…

…mong patients with coexisting ischaemic heart disease (IHD) and type 2 diabetes (T2D) in primary care, in relation to European guidelines.Desig…

…a was not associated (OR=1.00, 95% CI 0.70 to 1.42).Conclusions Amblyopia is associated with long-term systemic health conditions, sugges…

…velopment of cardiovascular diseases, arterial hypertension and type 2 diabetes. While countermeasures such as nap at work have been suggested …

…ctorial traits in IVF (in vitro fertilisation) embryos, such as type 2 diabetes, cardiovascular diseases and various other characteristics like…

…ration rate. 22 The study included adults (n=1229) with stage 3 chronic kidney disease (estimated glomerular filtration rate 30-59 mL/min/1.73 m2 incl…

…LP-1 agonist injections, although originally developed to treat type 2 diabetes, have changed how we approach obesity.1 The two main types now …

…ent medications of recent years. Initially approved in 2021 for type 2 diabetes in adults, semaglutide is now authorised for obesity management…